Latest / Bloomberg Intelligence / Such Strong GDP Isn’t Sustainable: KPMG’s Hunter
Transcript
- 0:05Speaker 1: Welcome to the Bloomberg p m L Podcast. I'm pim Fox.
- 0:08Speaker 1: Along with my co host Lisa Bramowitz. Each day we
- 0:11Speaker 1: bring you the most important, noteworthy, and useful interviews for
- 0:15Speaker 1: you and your money, whether you're at the grocery store
- 0:17Speaker 1: or the trading floor. Find the Bloomberg p m L
- 0:20Speaker 1: Podcast on Apple Podcasts, SoundCloud, and Bloomberg dot com. We
- 0:30Speaker 1: are broadcasting live from the Bloomberg Interactive Broker's studios. We
- 0:35Speaker 1: did get the third quarter GDP report out earlier this morning.
- 0:39Speaker 1: It came in ahead of expectations three point five percent.
- 0:42Speaker 1: And interesting, that's an annualize right. Interestingly enough, the director
- 0:46Speaker 1: of the U S Office of Management and Budget mcmulvaney
- 0:49Speaker 1: came on Bloomberg Television. He said he expects this pace
- 0:52Speaker 1: of growth to be sustainable. That is a key question here,
- 0:56Speaker 1: and we are going to ask it of Constance Hunter,
- 0:59Speaker 1: Chief Economistic APMG, who joins us here in our eleven
- 1:01Speaker 1: three studios. Constants, do you think that three point is
- 1:05Speaker 1: a sustainable annual rate of growth for US economy in
- 1:10Speaker 1: the years ahead? I do not, and let me tell
- 1:12Speaker 1: you why. There's a couple of reasons. First, if you
- 1:15Speaker 1: look at potential GDP, which is the growth rate of
- 1:18Speaker 1: the sum of the working age population plus the growth
- 1:21Speaker 1: rate of productivity. That puts us it about a one
- 1:24Speaker 1: point eight percent GDP growth. Now, we could have a
- 1:27Speaker 1: productivity surge, right, could happen, But productivity is very difficult
- 1:32Speaker 1: to predict um and so far we've had very lackluster
- 1:36Speaker 1: capital deepening that is the amount of capital investment per
- 1:40Speaker 1: labor hour during this expansion. It really lacks previous expansions.
- 1:45Speaker 1: And so that would suggest that a productivity surge, while possible,
- 1:49Speaker 1: is not something I would bank on. Now you put together,
- 1:53Speaker 1: you and the folks at KPMG. You put together this
- 1:55Speaker 1: great chart where you break down all of the components
- 1:59Speaker 1: of g d P, and I want to go through
- 2:02Speaker 1: some of them if you don't mind talk a little
- 2:04Speaker 1: bit about residential investment. Yes, so we actually looked at
- 2:08Speaker 1: just to sort of analyze this question. Okayen does it
- 2:11Speaker 1: put it on a on a different trajectory than the
- 2:15Speaker 1: previous years and the expansion. So we have took the
- 2:17Speaker 1: first half and annualized the pace of growth. And now
- 2:20Speaker 1: we've taken the first three quarters of the year and
- 2:22Speaker 1: annualize this pace of growth. And it looks pretty good.
- 2:25Speaker 1: Consumptions a little stronger, we have business investment inching up
- 2:29Speaker 1: a little bit more. Uh. But the thing that's really
- 2:31Speaker 1: concerning is that residential fixed investment is down compared to
- 2:36Speaker 1: UM the full year residential fixed investment, so that's housing
- 2:40Speaker 1: investment is down, and that is a big concern because
- 2:44Speaker 1: housing is a leading indicator and if you recall it,
- 2:47Speaker 1: prices started to detern for housing in two thousand and six,
- 2:51Speaker 1: when everybody was still popping their champagne and saying raw
- 2:54Speaker 1: raw c D O S. Well. But I want to
- 2:57Speaker 1: pick up exactly on this, right, this decline of the
- 3:00Speaker 1: first time since late to thousan date in early two
- 3:02Speaker 1: thousand nine, right, So this is uh, this is an
- 3:04Speaker 1: unusual development, this decline in residential investments. And I'm just wondering,
- 3:10Speaker 1: given the fact that homeownership has changed and that more
- 3:13Speaker 1: people rent, fewer people own and have their sort of
- 3:16Speaker 1: net worth tied up with their residence, could it be
- 3:20Speaker 1: different this time? Well, it could be different in terms
- 3:24Speaker 1: of the impact on households. And certainly, UM there have
- 3:27Speaker 1: been tighter lending standards, so I wouldn't expect if we
- 3:31Speaker 1: even had I mean and remember, house prices declining is
- 3:35Speaker 1: actually not the norm. What happens when housing gets softer
- 3:39Speaker 1: as you see less investment there, you you see you
- 3:41Speaker 1: don't see the multiplier effects of an expanding um expanding
- 3:46Speaker 1: housing markets. You don't see another housing crash coming. Is
- 3:48Speaker 1: that we basically housing crisis? But but I think it's
- 3:51Speaker 1: a warning sign in terms of the overall strength of GDP.
- 3:55Speaker 1: And there are some really important structural reasons why housing
- 3:58Speaker 1: has an advance. I mean there that is one area
- 4:01Speaker 1: where there are severe construction shortages. Another area where there's
- 4:04Speaker 1: shortages is in transportation, so getting the materials to the builders. Um.
- 4:09Speaker 1: And then there's of course increase in prices for building materials,
- 4:12Speaker 1: so you've an increasing cost of labor and increasing cost
- 4:15Speaker 1: of materials and a shortage of labor, so people can't
- 4:18Speaker 1: do projects that they want to do. So this is
- 4:21Speaker 1: a classic macroeconomic business cycle situation. Right, This is exactly
- 4:26Speaker 1: what causes slowdowns of the business cycle, is you have
- 4:29Speaker 1: supply constraints that prevent expansion and then in fact bring
- 4:33Speaker 1: about declines. Tell us about business investment right now? Yes, so, um,
- 4:39Speaker 1: we saw this quota decline in structures. Well, let me
- 4:42Speaker 1: actually go out to thirty feet first, So business investment
- 4:46Speaker 1: has been on an upswing for about six quarters seven quarters,
- 4:50Speaker 1: and uh when we started this year, of course, we
- 4:53Speaker 1: had the tax law change, and we saw a surge
- 4:56Speaker 1: in business investment in the first half of the year.
- 4:58Speaker 1: So moving up around ten percent is five point three
- 5:01Speaker 1: percent for all. Now it's a little bit more moderated,
- 5:04Speaker 1: Right's up six point three percent on an annualized basis,
- 5:07Speaker 1: So a faster pace, but a faster pace that you
- 5:10Speaker 1: would expect. This had been accelerating, and I say you
- 5:12Speaker 1: would expect absent any tax law change. So this is
- 5:16Speaker 1: going to be debated for a long time. Has this
- 5:19Speaker 1: increase in business investment this year been as a result
- 5:21Speaker 1: of the tax wealth change or a result of the
- 5:23Speaker 1: trend that was already under way at the end of
- 5:28Speaker 1: into So given the fact that we actually saw not
- 5:32Speaker 1: a decrease but a slowdown in business expenditures investments in
- 5:37Speaker 1: the third quarter, does that give you confidence in one
- 5:41Speaker 1: view or another in terms of the tax cuts playing
- 5:44Speaker 1: a role or not? No, Um, I mean it, and
- 5:47Speaker 1: it doesn't even make me overly concerned. In general, we
- 5:50Speaker 1: sell structures decline, but we saw um and we saw
- 5:54Speaker 1: a slower pace of growth in intellectual property and equipment,
- 5:59Speaker 1: but those numbers fluctuating in quarter to quarter. It's also
- 6:02Speaker 1: the first reading, so I I'm not going to get
- 6:05Speaker 1: overly concerned about that. But if you if you think
- 6:07Speaker 1: about how much of this was tax driven, I think
- 6:10Speaker 1: it's too soon to see those results. If you look
- 6:13Speaker 1: at surveys of business leaders and ceo s, they say
- 6:18Speaker 1: of them say they weren't planning to change their investment
- 6:20Speaker 1: plans based on the tax I'll change. And as Pam
- 6:23Speaker 1: and I were talking about before the show, right that
- 6:25Speaker 1: this is something that business leaders take a long time
- 6:27Speaker 1: to plan. It's not something you really can do on
- 6:30Speaker 1: the fly. There's maybe a few investments, but basically this
- 6:33Speaker 1: is a long term trend. Thank you very much for
- 6:35Speaker 1: coming in and spending time with us. Constance Hunter, Chief
- 6:38Speaker 1: Economist KPMG, and of course you can follow Constance Hunter
- 6:43Speaker 1: on Twitter at Constance Hunter. We're looking at a sell
- 6:47Speaker 1: off in stocks, the SMP five right now down one
- 6:50Speaker 1: and three quarters of a percent. You're listening to Bloomberg
- 6:54Speaker 1: Markets driving the action today and markets very much is
- 7:07Speaker 1: the Amazon and Alphabet reports that came out overnight or
- 7:10Speaker 1: after the bell yesterday basically giving a very negative tone
- 7:15Speaker 1: even though the uh the actual earnings were okay. Joining
- 7:20Speaker 1: us now, David Garretty, chief market strategist at laid Law
- 7:22Speaker 1: and Company in Brooklyn, David, thank you so much for
- 7:25Speaker 1: being here. I wanted just to ask you. Can you
- 7:28Speaker 1: start by saying what was your impression of the earnings?
- 7:31Speaker 1: Do you think that markets are misinterpreting them? The earnings
- 7:34Speaker 1: themselves are fairly solid. However, if one looked at Amazon,
- 7:38Speaker 1: there was a deceleration in terms of growth quarter to quarter,
- 7:41Speaker 1: also Google showing some challenges in terms of their top
- 7:44Speaker 1: line revenue growth. Obviously, the bigger thing here is the
- 7:48Speaker 1: fact that even though interest rates have been going up,
- 7:52Speaker 1: even though the market has been selling off, we hadn't
- 7:54Speaker 1: seen analysts bring in their own expectations. And anytime there
- 7:58Speaker 1: is a shortfall relative expectations, there has to be a reset. Obviously,
- 8:02Speaker 1: analysts need to start bringing their numbers down. But as
- 8:06Speaker 1: we also looked inside the results for both of these companies,
- 8:08Speaker 1: Alphabet as well as Amazon, we saw that they're raising
- 8:11Speaker 1: their spending levels, which is going to have an impact
- 8:13Speaker 1: on near term profit margins, which is going to further
- 8:16Speaker 1: serve to further reduce earnings expectations. So, from that standpoint,
- 8:21Speaker 1: anytime there's a shortfall versus expectations, yes, one could say
- 8:25Speaker 1: it's the fault of the street, but the fact of
- 8:27Speaker 1: the matter is that these companies shares trade within something
- 8:31Speaker 1: called the stock market that's populated by expectations, and if
- 8:35Speaker 1: the company's performance is out of line with expectations, there
- 8:38Speaker 1: has to be a reset on both sides. David Garritty,
- 8:41Speaker 1: if you love the shares of Amazon at the end
- 8:44Speaker 1: of September, you have lost about seventeen and a half percent.
- 8:50Speaker 1: Is it time to buy Amazon? If you love it
- 8:53Speaker 1: at two thousand and six dollars a share? Do you
- 8:57Speaker 1: love it at six and thirty three share? Certainly, we're
- 9:02Speaker 1: at a point in time during the year, going into
- 9:04Speaker 1: the fourth quarter, with the year end holiday shopping season
- 9:07Speaker 1: in front of us that historically has been the seasonally
- 9:10Speaker 1: strongest quarter in terms of earnings and results for Amazon,
- 9:13Speaker 1: going back historically, if one wanted to trade what one's
- 9:17Speaker 1: own expectations might be as what that fourth quarter is, fine,
- 9:21Speaker 1: this may not be a bad point in time to
- 9:23Speaker 1: consider a short term trade. However, at the same time,
- 9:26Speaker 1: offset that against the fact that we had a very solid,
- 9:30Speaker 1: better than expected GDP growth print for the third quarter
- 9:33Speaker 1: at three and a half percent, which obviously is going
- 9:35Speaker 1: to leave the Federal Reserve in a position of raising
- 9:38Speaker 1: interest rates going further into two thousand nineteen. Higher interest
- 9:42Speaker 1: rates always mean greater valuation challenges for high pe valuation
- 9:48Speaker 1: names such as an Amazon, especially as they don't pay
- 9:50Speaker 1: a dividend and give you a total return. So if
- 9:52Speaker 1: you want to have a trade around the fourth quarter results,
- 9:54Speaker 1: but it's just a trade, it's not a long term
- 9:56Speaker 1: buy in your opinion, I think until such time as
- 9:59Speaker 1: we're out of the woods terms of the FED tightening cycle, um,
- 10:02Speaker 1: these names are going to be a little bit challenged.
- 10:04Speaker 1: You're certainly seeing reallocation by investors away from tech names
- 10:10Speaker 1: towards more lower volatility, higher earning certainty names such as
- 10:14Speaker 1: Staples in terms of its sector over the course of October.
- 10:17Speaker 1: I like how you talked about spending, and I think
- 10:19Speaker 1: this is important because not all spending is equal. What
- 10:22Speaker 1: are they spending the money on and is it something
- 10:25Speaker 1: that could give them growth leader on and keep them
- 10:28Speaker 1: as being growth stocks. Certainly there continues to be investment
- 10:32Speaker 1: on their part in terms of high ticket items such
- 10:35Speaker 1: as data centers, which certainly give them the capacity for
- 10:37Speaker 1: future growth. But as we know, looking at the results
- 10:40Speaker 1: that came out of Microsoft earlier this week, Microsoft in
- 10:44Speaker 1: terms of their online cloud services Azure, we're doing much
- 10:48Speaker 1: better in growth terms than you saw either coming out
- 10:50Speaker 1: of Amazon, who has been the leader in this category
- 10:52Speaker 1: with their Amazon Web Services business, or with Google in
- 10:56Speaker 1: this regard. So clearly you're seeing more competitive market. Um.
- 10:59Speaker 1: I would also add maybe not so much for an Amazon,
- 11:02Speaker 1: but I would say that relative to a Google, along
- 11:04Speaker 1: with other social media names like a Facebook and a Twitter.
- 11:07Speaker 1: You know, we're not only going up against the Federal
- 11:09Speaker 1: Reserve tightening interest rates, but we're also facing greater regulatory scrutiny,
- 11:13Speaker 1: which might intensify should the Democrats take the House of
- 11:16Speaker 1: Representatives On November six. David Garritty taking a look at Apple.
- 11:21Speaker 1: They report their results after the close on the first
- 11:24Speaker 1: of November. The stock is up about twenty seven and
- 11:28Speaker 1: a half percent so far this year. It pays a dividend.
- 11:31Speaker 1: What are your thoughts on Apple? In terms of Apple,
- 11:34Speaker 1: I mean, the company has demonstrated a policy of returning
- 11:37Speaker 1: capital the shareholders, either through buybacks or through raising their dividend.
- 11:42Speaker 1: Um we see the company's growth in their services business
- 11:46Speaker 1: being a certainly an important driver for further gains in
- 11:50Speaker 1: cash flow to sustain that kind of pattern of return generation.
- 11:55Speaker 1: We do note, however, that smartphone volumes as a whole
- 11:58Speaker 1: looking across the mark it, the growth there basically has
- 12:02Speaker 1: come down to low single digits, a more competitive market.
- 12:05Speaker 1: But we think if we look at Apple from evaluation standpoint,
- 12:09Speaker 1: and we look at us a total return vehicle, we're
- 12:11Speaker 1: far more comfortable owning an Apple than we are saying
- 12:13Speaker 1: owning UM, an Amazon or a Facebook. Alright, So over
- 12:17Speaker 1: the next two years, since you don't see this as
- 12:18Speaker 1: a long term by if the FED does continue to
- 12:22Speaker 1: raise rates, how much more do you think the fang
- 12:25Speaker 1: stocks have to sell off before they've become attractive on
- 12:28Speaker 1: a long term basis. Some of the work I've seen
- 12:30Speaker 1: coming out elsewhere on the street have indicated that, you know,
- 12:33Speaker 1: if we were to see an under performance by tech
- 12:36Speaker 1: names versus the staples sector by maybe another three to
- 12:39Speaker 1: five percent, that there might be what people would call
- 12:42Speaker 1: sort of a near term bottom being put in. But
- 12:45Speaker 1: we also have to consider that, you know, we've been
- 12:47Speaker 1: operating here in a stock market since March of two
- 12:49Speaker 1: thousand nine, where we've had a commendative monetary policy, not
- 12:53Speaker 1: just in the US but globally, and all of this
- 12:56Speaker 1: obviously has to be wound back, if you will, if
- 13:00Speaker 1: we're going to position ourselves to address the possibility of
- 13:03Speaker 1: a recession in two thousand twenty, which other companies such
- 13:06Speaker 1: as a JP Morgan have started to put odds on
- 13:09Speaker 1: that we're going to have a recession in eighteen months.
- 13:12Speaker 1: If that happens, the monetary authorities have to have the
- 13:15Speaker 1: capability to respond to that downturn, which means that they
- 13:18Speaker 1: do need to unwind this easing that we saw so
- 13:21Speaker 1: for earlier in this cycle. David Garty, I'm taking a
- 13:24Speaker 1: look at Facebook. You mentioned Facebook as another stock where
- 13:29Speaker 1: you're not necessarily that eager to add to position or
- 13:32Speaker 1: even engage a new position. The stock has lost more
- 13:35Speaker 1: than thirty percent of its value since July. Since mid July,
- 13:40Speaker 1: you'd have to go back to June of last year
- 13:44Speaker 1: to find a comparable price. Trading at a hundred and
- 13:46Speaker 1: forty six dollars a share. Is Facebook on sale or
- 13:51Speaker 1: is it just accurate more accurately priced I think Facebook
- 13:55Speaker 1: is pricing in the greater regulatory burdens that they're dealing with.
- 13:59Speaker 1: Clear we spoke earlier about congressional scrutiny here in the US.
- 14:03Speaker 1: We have also previously on this air spoken about in
- 14:06Speaker 1: the EU the imposition of the Global Data Privacy Regulations
- 14:11Speaker 1: or g DPR, which took place in May. I'd make
- 14:14Speaker 1: the argument here that until such time as we start
- 14:17Speaker 1: to anniversary i e. Going into the second half of
- 14:20Speaker 1: two thousand nineteen of GDP g DPR being put on
- 14:24Speaker 1: the books, Facebook is going to be under a bit
- 14:26Speaker 1: more pressure. So they're not just fighting the FED, but
- 14:29Speaker 1: they're fighting regulators here at home and abroad. Before we
- 14:32Speaker 1: let you go, I'm really curious on your views on Twitter,
- 14:35Speaker 1: because Twitter is bucking this trend, reported better than expected
- 14:39Speaker 1: earning is even with the decline in actual users due
- 14:42Speaker 1: to their crackdown on bots and other things. Um, what
- 14:46Speaker 1: do you think about Twitter going forward? Um? Twitter faces
- 14:49Speaker 1: the same dynamic from a regulatory standpoint. Clearly, Um, you know,
- 14:53Speaker 1: we would argue at the same time that you know,
- 14:56Speaker 1: while they may be getting to profitability by shrinking their base.
- 15:00Speaker 1: I've followed other industries in the past where shrinking one's
- 15:03Speaker 1: way to profitability was not necessarily one's way to higher
- 15:06Speaker 1: share price. So I think until we start to get
- 15:09Speaker 1: better definition as to how it is that the social
- 15:12Speaker 1: media names are going to be able to operate after
- 15:15Speaker 1: these regulatory changes are put into effect, we probably sit
- 15:20Speaker 1: back on the sidelines in terms of these stocks and
- 15:22Speaker 1: let them find their own level. Well done, Thanks very
- 15:26Speaker 1: much for being with us. David Garerty, chief market strategist
- 15:29Speaker 1: for laid Law and Company. Congratulations on your new position.
- 15:33Speaker 1: Much appreciated. We are broadcasting live from the Bloomberg Interactive
- 15:47Speaker 1: Broker's studios just to reiterate this development. The US Justice
- 15:50Speaker 1: Department said that one person is now in custody in
- 15:53Speaker 1: connection with the mailing of suspected explosive devices that targeted
- 15:56Speaker 1: high profile democrats. They are holding a news friends today
- 16:00Speaker 1: at two thirty pm Eastern times, so we will bring
- 16:03Speaker 1: you more when we get it. Right now, though, it
- 16:06Speaker 1: is time to turn our attention to the semiconductor space,
- 16:10Speaker 1: the chip sector that has been beaten up pretty broadly
- 16:13Speaker 1: over the past few weeks. A non street of Austin
- 16:16Speaker 1: joins us right now. A non street of Austin, a
- 16:17Speaker 1: senior Semiconductor and Hardware analyst for Bloomberg Intelligence and on.
- 16:22Speaker 1: It's actually a little bit challenging to get a consistent
- 16:25Speaker 1: story when you look at the shares across the board,
- 16:27Speaker 1: because Intel is doing great, but a m D is
- 16:30Speaker 1: absolutely getting crushed along with broad common Qualcolm, what's going
- 16:33Speaker 1: on here? Yeah, it's kind of hard to um sometimes
- 16:36Speaker 1: separate the week from the shelf if you, if you may,
- 16:38Speaker 1: but to schools of thought here, right, So it's all
- 16:41Speaker 1: semi conductor cycle all the time. The semiconductor index has
- 16:45Speaker 1: gone from a level of four hundred to four hundred
- 16:48Speaker 1: over a period of five and a half years school thought.
- 16:51Speaker 1: School of thought number one is that this was an
- 16:54Speaker 1: unheralded extended up cycle, and we will pay the price
- 16:58Speaker 1: on the downside and it will be an unnerralded extended
- 17:01Speaker 1: down cycle, in which case this is time to abandon
- 17:05Speaker 1: the chips for an extended period of time. School of
- 17:08Speaker 1: start number two is that this is a substantially better
- 17:11Speaker 1: industry with multiple demand drivers, more diversified, and as a result,
- 17:16Speaker 1: you're going to have a shallower downturn, and semiconductors being
- 17:20Speaker 1: the new industrials, you will have shallower up cycles. And
- 17:24Speaker 1: shallower down cycles as has been the case, the smaller
- 17:27Speaker 1: dips being more indicative of of the downturn. So UH
- 17:32Speaker 1: semmy's have been beaten up pretty badly in the last month. UM.
- 17:37Speaker 1: If you look at a m D and video down
- 17:40Speaker 1: in video down, so they've been beaten up. But there's
- 17:44Speaker 1: no question that down cycles underway. The question is how
- 17:48Speaker 1: shallow or deep will it be? On does this reflect
- 17:52Speaker 1: and market demand? So so Intel's UM. Intel has an
- 17:56Speaker 1: opportunity to really change in the narrative here and then
- 18:00Speaker 1: try to spend it such that PCs and servers are
- 18:03Speaker 1: somewhat exempt from that that this is a vertical specific downturn.
- 18:07Speaker 1: I'm not a big believer in that camp. Usually once
- 18:10Speaker 1: UH the bug catches, it spreads all through the all
- 18:16Speaker 1: through the sector, So no particular in market is usually immune.
- 18:20Speaker 1: And it's also reflective of the fact that UM corporate
- 18:23Speaker 1: I T spending has been on a boom. UM service
- 18:26Speaker 1: spending has been is good, PCs uptick for the first
- 18:30Speaker 1: time up to percent UH in several years. So all
- 18:33Speaker 1: of that you can make a case for UM. But
- 18:35Speaker 1: you can either say, Okay, it hasn't broken yet or
- 18:39Speaker 1: it's actually been a little bit on the mend, and
- 18:41Speaker 1: the other sectors have to catch up. I watched away
- 18:43Speaker 1: in exactly sort of the potential scenarios that you initially
- 18:46Speaker 1: laid out in particular, you know what do we have
- 18:49Speaker 1: to see to know that this is going to be
- 18:51Speaker 1: a protracted and deep decline in this entire industry at
- 18:55Speaker 1: a time when we do get some disappointing We have
- 18:57Speaker 1: gotten some disappointing earnings at a big tech and they're
- 19:00Speaker 1: kind of a saturation point when it comes to certain
- 19:03Speaker 1: technologies that really are are heavy in the chip industry.
- 19:06Speaker 1: Absolutely look so UM semi conductors are sort of the
- 19:11Speaker 1: tip of the spear, if you may. In order to
- 19:12Speaker 1: see a protracted, extended downturn, there has to be a
- 19:15Speaker 1: macro collapse, right UM, semi see. At first, you can
- 19:19Speaker 1: make the case through tariffs. You can make the case
- 19:22Speaker 1: through global GDP growth. UM, But I'm not in that
- 19:26Speaker 1: camp UM, not being a macro sire, but also that UM,
- 19:32Speaker 1: there are just too many irons in the fire. From
- 19:35Speaker 1: our demand perspective. You have a third of the demand
- 19:38Speaker 1: being the PC supply chain. You have a third of
- 19:40Speaker 1: the semiconductor industry being the handset supply chain. But you
- 19:43Speaker 1: have autos, you have industrials, you have um other subsectors
- 19:47Speaker 1: that are perhaps not as big and and PCs are
- 19:50Speaker 1: doing okay right now, so you can make the case,
- 19:53Speaker 1: but autos are not, so a bunch of those other
- 19:55Speaker 1: other parts are not. That's a that's a great point.
- 19:57Speaker 1: Autos and industrials, however, are growing, but more due to
- 20:02Speaker 1: content rather than gizmo growth. With PCs and handsets, gizmo
- 20:06Speaker 1: growth was almost as important as stuff inside the gizmo.
- 20:10Speaker 1: Semiconutters grow in two a way, two ways, right. Once
- 20:13Speaker 1: you ship more handsets and PCs option A or the
- 20:16Speaker 1: content within the handset and the PC expand. So when
- 20:19Speaker 1: these particular devices grew, the stuff within the gizmo also
- 20:25Speaker 1: grew versus. If you look at autos and industrials, these
- 20:27Speaker 1: are pretty well established market, but stuff in the gizmo
- 20:31Speaker 1: is growing. So if you look at content growth within
- 20:34Speaker 1: a car up from two seven years ago to somewhere
- 20:37Speaker 1: in the five plus range right now, depending on what
- 20:41Speaker 1: subsectors you include in there. So industrials, the same thing
- 20:44Speaker 1: IoT distributed, so you can make the case for an extended,
- 20:48Speaker 1: extended up cycle. But these are smaller subsectors a third
- 20:52Speaker 1: of the business, handsets a third of the business, pecs,
- 20:56Speaker 1: um SO and and therein lies the ama of their
- 21:00Speaker 1: two schools of thought with the cycle, Ana, can you
- 21:03Speaker 1: speak to the memory chip demand issue? Yeah? So memory member,
- 21:06Speaker 1: that's a great point um and memory is ubiquitous. It
- 21:10Speaker 1: goes into everything, right. Memory density or memory capacity for
- 21:15Speaker 1: device has been on a tear across devices. But there
- 21:19Speaker 1: has been built up of over capacity in the industry
- 21:22Speaker 1: and the question is is there enough absorption of that
- 21:26Speaker 1: over capacity over a short period of time to get
- 21:30Speaker 1: supply and demand back into balance. The big driver of
- 21:33Speaker 1: that was the cloud data center market um and um
- 21:38Speaker 1: UH and the SSD business, and there was a big
- 21:40Speaker 1: move from flash from heart descrives to flash. So those
- 21:44Speaker 1: are the big consumers, but prices collapsing the way they
- 21:47Speaker 1: are given over supply. Will that extra demand be absorbed
- 21:50Speaker 1: and how soon will be absorbed? So I'm just wondering it.
- 21:54Speaker 1: Just to wrap up here, which companies are most exposed
- 21:59Speaker 1: to the o an industrial space where the insides are
- 22:02Speaker 1: expanding and maybe the gizmos aren't versus those that are
- 22:07Speaker 1: more exposed to the PCs and phones and things where
- 22:12Speaker 1: you know there's much less kind of room to expand.
- 22:14Speaker 1: Absolutely so um n XP Semiconductors, which is UM which
- 22:19Speaker 1: was just coming out of the broken M and a
- 22:21Speaker 1: deal with Qualcom. Um is one of the leaders in
- 22:25Speaker 1: auto market share. Um Texas Instruments has high auto market share,
- 22:29Speaker 1: st micro Electronics and in Finian out of Germany. Well,
- 22:34Speaker 1: thanks for being with us as always illuminating on on Trinivason,
- 22:38Speaker 1: senior semiconductor and hardware analysts for Bloomberg in Intelligence. We
- 22:53Speaker 1: are broadcasting live from the Bloomberg Interactive Broker's studios on
- 22:57Speaker 1: this Friday. President Trump yesterday announced a drug pricing proposal,
- 23:02Speaker 1: and here to talk a little bit about that is
- 23:04Speaker 1: Max Sneathan, Biotech, farm and healthcare columnist for Bloomberg Opinion. Max,
- 23:09Speaker 1: wonderful to see you. So first, can you just give
- 23:11Speaker 1: us a sort of outline of what President Trump is proposing. Yeah. Absolutely,
- 23:15Speaker 1: So it's a three part plan, a demonstration through the
- 23:19Speaker 1: Center for Medicare and Medicaid Services Office of Innovation, so
- 23:23Speaker 1: not something that requires extra legislation and sort of a
- 23:27Speaker 1: three pronged approach. The first is to give some some
- 23:31Speaker 1: vendors in the private sector more power to negotiate with
- 23:33Speaker 1: drug makers. The second to change the way that doctors
- 23:36Speaker 1: are reimbursed for some medicines from a six percent on
- 23:40Speaker 1: top of the average will sale price to a flat fee.
- 23:42Speaker 1: And then the most important one is to benchmark a
- 23:46Speaker 1: series of expensive drugs paid through for medica through Medicare.
- 23:49Speaker 1: Part b uh, they're gonna benchmark them too cheaper international
- 23:52Speaker 1: prices and over the period of five years, UM mandate
- 23:56Speaker 1: that you know, Medicare will start reimbursing at that low
- 24:00Speaker 1: or average rate because the rest of the the world
- 24:03Speaker 1: pays substantially lower lower prices for those medicines that we do.
- 24:07Speaker 1: By some analysis, Americans spend nearly nine hundred dollars per
- 24:13Speaker 1: person on prescription drugs each year. That's twice as much
- 24:18Speaker 1: as Australians and three times as much as the people
- 24:23Speaker 1: in the Netherlands. Why uh so that actually ends up
- 24:28Speaker 1: being a really interesting question with this international price index.
- 24:31Speaker 1: The reason is that other countries are much more willing
- 24:34Speaker 1: to say no to highly priced medicines to enact price controls.
- 24:39Speaker 1: All of that comes at a cost to access you
- 24:41Speaker 1: know people, Um the average person well those countries is
- 24:44Speaker 1: less likely to be able to access the most advanced
- 24:47Speaker 1: possible therapy uh than someone in America usually. But the
- 24:53Speaker 1: kind of upside of that is the fact that they
- 24:54Speaker 1: end up paying dramatically less for medicines because they're willing
- 24:57Speaker 1: to play hardball in a way that we're not. Nope, Max,
- 25:00Speaker 1: you've come on the show before and you've talked about
- 25:02Speaker 1: previous uh proposals from President Trump for people who work
- 25:06Speaker 1: for him, and you've said, this is kind of no meat.
- 25:10Speaker 1: Here is this the same thing? I think this is
- 25:13Speaker 1: the first time that that I really think that that
- 25:16Speaker 1: you know, if it happens, and that's un enormous if
- 25:18Speaker 1: and we can talk about why it would bring down prices.
- 25:22Speaker 1: And again, this is a subset of a subset of
- 25:25Speaker 1: the drug market. It's just half the country uh and
- 25:29Speaker 1: just part B medicines for the National Pricing Index. But
- 25:32Speaker 1: since those prices are so much lower, um, if you
- 25:35Speaker 1: actually you know, follow through with this index, prices in
- 25:37Speaker 1: the United States will come down for for seniors um.
- 25:41Speaker 1: And you know, it's sort of a curious way to
- 25:43Speaker 1: go about it in that we're sort of importing the
- 25:46Speaker 1: sort of price controls and restrictions that we you know
- 25:49Speaker 1: that the administration has said it previously doesn't like just
- 25:53Speaker 1: kind of doing a back war way, a backdoor way
- 25:55Speaker 1: of of importing them. So so it's an interesting way
- 25:58Speaker 1: to go about it, but it should actually bring down
- 26:01Speaker 1: prices that mostly because you know, theoretically drug makers could
- 26:05Speaker 1: raise prices elsewhere. That's sort of the angle that the
- 26:08Speaker 1: administration is going with to sort of explain ideologically what
- 26:11Speaker 1: seems like a a sort of incongruous move from them. Um, Basically,
- 26:16Speaker 1: they're saying, you know, we're they're freeloading off of us.
- 26:19Speaker 1: We're paying for the innovation and they're benefiting from us.
- 26:22Speaker 1: But it's it's not so easy as to go to
- 26:24Speaker 1: the UK and say we're raising the price. The UK
- 26:27Speaker 1: can just say well no, then they they've proven themselves
- 26:30Speaker 1: willing to do that. So um yeah, that's why I
- 26:33Speaker 1: do think the price will actually come down here if
- 26:35Speaker 1: this goes goes ahead. All right, well, let's just to
- 26:37Speaker 1: offer us I'll offer some examples and get your thoughts
- 26:40Speaker 1: on this. The price of a vast and, which is
- 26:43Speaker 1: a cancer drug. In the United States, you're gonna end
- 26:48Speaker 1: up paying about four thousand dollars for a vast and
- 26:52Speaker 1: in Switzerland you pay under two grand. In Spain, you're
- 26:56Speaker 1: paying about and you mentioned the United Kingdom, you're paying
- 26:59Speaker 1: a at five dollars for the same drug, harvony, which
- 27:04Speaker 1: is the HEPSI drug. You're paying like thirty five thousand
- 27:09Speaker 1: dollars in the United States, and in you know, Switzerland,
- 27:12Speaker 1: you're paying sixteen seventeen thousand. Way do those numbers come from?
- 27:17Speaker 1: Who sets that price? Uh, it's it's the drug maker,
- 27:20Speaker 1: and and it's all within the context of a different system.
- 27:24Speaker 1: Like you know that that harvony price after discounts in
- 27:27Speaker 1: the commercial market is probably a little bit lower. But
- 27:29Speaker 1: of vastin is actually a really good example here. It
- 27:32Speaker 1: is a biologic administered in doctor's office, is so apart
- 27:35Speaker 1: be drug and one that's used for cancer patients, so
- 27:38Speaker 1: one that has a lot of Medicare reimbursement UM. And
- 27:42Speaker 1: in this case, you know, part of it is just
- 27:44Speaker 1: that these healthcare systems are are willing to play hardball
- 27:47Speaker 1: when they negotiate. They negotiate on behalf of the entire
- 27:50Speaker 1: country in many cases, as opposed to kind of the
- 27:52Speaker 1: piecemeal way we do that UM. And also the other
- 27:56Speaker 1: thing is that there's more robust biosimilar competition in other
- 27:59Speaker 1: countries have been quicker about um getting competition to the
- 28:03Speaker 1: market for these expensive drugs. So we're hoping to sort
- 28:05Speaker 1: of both import that more aggressive negotiation and the more
- 28:09Speaker 1: aggressive competition for biologics. So of these markets, I want
- 28:12Speaker 1: to go to something that you hinted at, which you
- 28:14Speaker 1: said that if this gets implemented, and it's a very
- 28:18Speaker 1: big if, and we could talk about it. So let's
- 28:20Speaker 1: talk about it. Why is it such a sort of
- 28:22Speaker 1: long shot? It sounds like you think so. Um. One
- 28:25Speaker 1: thing that this is reminiscent of two people that have
- 28:27Speaker 1: been following drug prices for a long time is a
- 28:30Speaker 1: similar CMS demonstration by the Obama administration that also tried
- 28:35Speaker 1: to move physician reapbursement to a flat fee and implement
- 28:39Speaker 1: a variety of reference pricing, though though a different one
- 28:42Speaker 1: in many ways, it was actually a milder proposal, but
- 28:45Speaker 1: it was absolutely ripped to shreds by the farmland physician
- 28:49Speaker 1: lobby and Republican lawmakers. This is really interesting, in other words,
- 28:55Speaker 1: that they're taking a page from the Obama administration and
- 28:57Speaker 1: crafting this proposal Republican Congress when we're not in favor
- 29:01Speaker 1: of this. Now President Trump is proposing it wouldn't it
- 29:04Speaker 1: potentially have a greater chance of getting through because there
- 29:07Speaker 1: is more likely to be Republicans support for it given
- 29:11Speaker 1: President Trump's leadership. Or do you think that that's still
- 29:14Speaker 1: it's not enough to sort of get this pushed through.
- 29:17Speaker 1: It's it's pretty unclear. It'll it'll take some time for
- 29:20Speaker 1: that to play out, but so far, Um, you know,
- 29:23Speaker 1: I'm thinking of a statement that that or and Hatch
- 29:25Speaker 1: made the center from Utah it was to call it
- 29:28Speaker 1: tepid would be would be exaggerating a little bit. Uh,
- 29:33Speaker 1: you know. So it's it's just sort of an awkward
- 29:35Speaker 1: and a little bit out of character proposal for Republicans
- 29:39Speaker 1: to support, and time will tell whether kind of the
- 29:42Speaker 1: Trump effect, um, you know, the kind of move towards
- 29:46Speaker 1: the populist will lead them to support something that they
- 29:50Speaker 1: they vehemently opposed. Another version of in the past, Max,
- 29:54Speaker 1: the United States has no government panel that negotiates drug prices. Correct, Uh,
- 30:02Speaker 1: that's correct. It's all left, for example, in the Medicare
- 30:05Speaker 1: part D to private plans and in part be the
- 30:08Speaker 1: part it's just kind of left up to the drug maker.
- 30:10Speaker 1: Supposed there's not much negotiation at all. Does that make
- 30:13Speaker 1: any sense. Um, you know, I mean the government is
- 30:18Speaker 1: the bill. It's basically, you know, letting one of the
- 30:21Speaker 1: world's largest purchasers of healthcare services and tossing one of
- 30:26Speaker 1: the biggest benefits of that, which is a huge amount
- 30:28Speaker 1: of negotiating power, tossing it by the wayside, and instead
- 30:31Speaker 1: of using that um going by this very complicated backdoor
- 30:36Speaker 1: um importation of other people's negotiating power for part of
- 30:39Speaker 1: the market. So yet that would one would think that
- 30:42Speaker 1: the more impactful proposal would be to just use that
- 30:46Speaker 1: negotiating power, but that that appears to still be off
- 30:49Speaker 1: the table. Thanks very much for being with us. Max
- 30:51Speaker 1: Neeson is always an expert when it comes to all
- 30:54Speaker 1: things healthcare. Bloomberg opinion columns covering the healthcare industry. You're
- 30:59Speaker 1: listening Bloomberg Markets. We should just say that the SMP
- 31:02Speaker 1: five hundred has fallen from its all time high. Also
- 31:06Speaker 1: ciana's reporting that authorities have arrested demand in Florida in
- 31:09Speaker 1: the explosives package case. We'll keep you posted. This is Bloomberg.
- 31:15Speaker 1: Thanks for listening to the Bloomberg P and L podcast.
- 31:18Speaker 1: You can subscribe and listen to interviews at Apple podcasts, SoundCloud,
- 31:22Speaker 1: or whatever podcast platform you prefer. I'm pim Fox. I'm
- 31:25Speaker 1: on Twitter at pim Fox. I'm on Twitter at Lisa Abramo.
- 31:29Speaker 1: It's One before the podcast. You can always catch us
- 31:32Speaker 1: worldwide on Bloomberg Radio